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Objectives: Sporadic Alzheimer’s disease (sAD) is the most
prevalent neurodegenerative pathology with no effective ther-
apy until date. This disease prompts hippocampal degeneration,
which in turn affects multiple cognitive domains and daily-life
activities. In this study, we hypothesized that long-lasting ther-
apy with human mesenchymal stem cells (MSC) would have
a restorative effect on the behavioral alterations and cognitive
decline characteristic of sAD, as they have shown neurogenic and
immunomodulatory activities.
Methods: We treated intracerebroventricular streptozotocin-
injected (icv-STZ) rats, a commonly used animal model of sAD, with
1 × 106 MSC in a tail vein (24 days post-icv-SZT), every 18 days. At
the end of the study (3 months post-icv-STZ), we evaluated their
cognitive function together with morphological and biochemical
changes in the hippocampus.
Results: We observed cognitive deficits, microgliosis, and
decreased on presynaptic proteins (SYT1, SYT2, and SYP) and
GABAergic neuron marker (GAD65) in the brains of icv-STZ rats.
Interestingly, MSC therapy significantly improved its spatial mem-
ory and decreased the anxiety, ameliorated microglial activation,
and enhanced SYT1, SYP, and GAD65 levels. Additionally, we found
significant negative correlation between the hippocampal reactive
microglia with the expression of SYT1, SYT2, SYP, and GAD67 pro-
teins, suggesting the modulation of synaptic transmission by glial
cells.
Conclusion: These findings, showing that intravenous injection
of human MSCs restores behavioral and hippocampal alterations in
experimental sAD, support the potential use of MSC therapy for the
treatment of neurodegenerative diseases.
https://doi.org/10.1016/j.ibror.2019.07.1503
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Autism spectrum disorder (ASD) is a neurodevelopmental dis-
order with an incidence three times higher in boys than in girls. By
analyzing the effect of sex in a mouse model of ASD, we were able
to identify immune alterations that could underlie this sex bias.
Pregnant mice were injected subcutaneously with 600 mg/kg
of valproic acid (VPA) or saline at gestational day 12.5. Their
male and female offspring were evaluated in a social interaction
test at adulthood, and only male VPA mice showed reduced
sociability levels and a lack of social preference. We then analyzed
the hypothalamus–pituitary–adrenal (HPA) response and the
neuroinflammatory state in adult and young animals. Adult VPA
males exhibited increased basal corticosterone levels, while VPA
females showed levels comparable to controls. As male mice
showed a blunted HPA activation at PD21 when compared to
female mice, we propose that this early dimorphism could explain
the different effects of VPA on HPA function. In addition, prenatal
VPA exposure resulted in altered astroglial and microglial cell
density levels in the dentate gyrus and the cerebellum in adult
mice. These neuroinflammatory effects were more pronounced
in female than male mice, and appeared at early developmental
stages. We propose that these postnatal glial density differences
could underlie the behavioral differences observed in adulthood,
when only males show a social deficit.
We consider that our work contributes to the understanding of
biological mechanisms affected by VPA on male and female rodents,
and to shed light on the study of possible resilience mechanisms in
the female population and/or susceptibility to ASD in boys.
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Psychostimulants produce different behavioral and neurobi-
ological profiles. For example, some drugs cause neuroplastic
changes leading to addiction and cognitive deficits while others
enhance cognition. Epigenetic mechanisms are known contribu-
tory factors to drug-induced neuroadaptations. These epigenetic
changes include dysregulation of histone deacetylases (HDACs)
proposed to participate in maintaining aberrant transcriptional
programs associated with altered cognitive functions and behav-
iors. HDACs are divided into zinc-dependent [class I (HDAC1,2,3,8),
class IIa (HDAC4,5,7,9), class IIb (HDAC6,10), and class IV (HDAC11)]
and NAD-dependent [class III (sirtuins1–7)] enzymes. Our laborato-
ries have previously reported that psychostimulants differentially
influence the acetylation status of histones 3 and 4 at promot-
ers of HDACs in the prefrontal cortex (Addict. Biol., 2019. doi:
10.1111/adb.12737). In the present study, we used acute admin-
istration of methamphetamine (1 mg/kg), modafinil (90 mg/kg),
caffeine (10 mg/kg) or methylphenidate (10 mg/kg) in C57BL/6
mice to investigate potential changes on the mRNA expression
of HDACs 4, 5 and 7 in the medial prefrontal cortex (mPFC) and
dorsal striatum (DS). All psychostimulants increased locomotion
at these doses. Modafinil decreased HDAC7 and HDAC5 mRNAs in
DS but increased their levels in mPFC. Methylphenidate increased
HDAC5 mRNA in mPFC but decreased it in DS. Methamphetamine
increased HDAC4 and HDAC5 mRNA levels but decreased HDAC7
expression in mPFC. Caffeine did not effect HDAC expression.
